136 related articles for article (PubMed ID: 11376245)
1. Mediastinal lymphoma: quantitative changes in gadolinium enhancement at MR imaging after treatment.
Rahmouni A; Divine M; Lepage E; Jazaerli N; Belhadj K; Gaulard P; Golli M; Reyes F; Vasile N
Radiology; 2001 Jun; 219(3):621-8. PubMed ID: 11376245
[TBL] [Abstract][Full Text] [Related]
2. MRI characterization of residual mediastinal masses in Hodgkin's disease: long-term follow-up.
Di Cesare E; Cerone G; Enrici RM; Tombolini V; Anselmo P; Masciocchi C
Magn Reson Imaging; 2004 Jan; 22(1):31-8. PubMed ID: 14972392
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up of residual mediastinal masses in treated Hodgkin's disease using MR imaging.
Nyman R; Forsgren G; Glimelius B
Acta Radiol; 1996 May; 37(3 Pt 1):323-6. PubMed ID: 8845262
[TBL] [Abstract][Full Text] [Related]
4. [Malignant lymphoma: magnetic resonance tomography findings in residual supradiaphragmatic space-occupying lesions].
Stroszczynski C; Hosten N; Oellinger J; Spahn G; Amthauer H; Bittner RC; Hierholzer J; Ludwig WD; Felix R
Rofo; 1999 Sep; 171(3):192-9. PubMed ID: 10520328
[TBL] [Abstract][Full Text] [Related]
5. Gd-DTPA-enhanced MR imaging in mediastinal Hodgkin's disease.
Forsgren G; Nyman R; Glimelius B; Hagberg H; Rehn S; Hemmingsson A
Acta Radiol; 1994 Nov; 35(6):564-9. PubMed ID: 7946679
[TBL] [Abstract][Full Text] [Related]
6. Renal lymphoma: demonstration by MR imaging.
Semelka RC; Kelekis NL; Burdeny DA; Mitchell DG; Brown JJ; Siegelman ES
AJR Am J Roentgenol; 1996 Apr; 166(4):823-7. PubMed ID: 8610558
[TBL] [Abstract][Full Text] [Related]
7. Residual mediastinal masses in Hodgkin disease: prediction of size with MR imaging.
Nyman RS; Rehn SM; Glimelius BL; Hagberg HE; Hemmingsson AL; Sundström CJ
Radiology; 1989 Feb; 170(2):435-40. PubMed ID: 2911665
[TBL] [Abstract][Full Text] [Related]
8. Comparison of magnetic resonance imaging and (67)gallium scintigraphy in the evaluation of posttherapeutic residual mediastinal mass in the patients with Hodgkin's lymphoma.
Herman M; Paucek B; Raida L; Myslivecek M; Zapletalová J
Eur J Radiol; 2007 Dec; 64(3):432-8. PubMed ID: 17478069
[TBL] [Abstract][Full Text] [Related]
9. Fast multiplanar spoiled gradient-recalled imaging of the liver: pulse sequence optimization and comparison with spin-echo MR imaging.
Low RN; Francis IR; Herfkens RJ; Jeffrey RB; Glazer GM; Foo TK; Shimakawa A; Pelc NJ
AJR Am J Roentgenol; 1993 Mar; 160(3):501-9. PubMed ID: 8381572
[TBL] [Abstract][Full Text] [Related]
10. MR imaging of the gastrointestinal tract with i.v., gadolinium and diluted barium oral contrast media compared with unenhanced MR imaging and CT.
Low RN; Francis IR
AJR Am J Roentgenol; 1997 Oct; 169(4):1051-9. PubMed ID: 9308464
[TBL] [Abstract][Full Text] [Related]
11. Dynamic contrast-enhanced subtraction versus T2-weighted spin-echo MR imaging in the follow-up of colorectal neoplasm: a prospective study of 41 patients.
Kinkel K; Tardivon AA; Soyer P; Spatz A; Lasser P; Rougier P; Vanel D
Radiology; 1996 Aug; 200(2):453-8. PubMed ID: 8685341
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance imaging of thymic epithelial tumors.
Kushihashi T; Fujisawa H; Munechika H
Crit Rev Diagn Imaging; 1996 Aug; 37(3):191-259. PubMed ID: 8872410
[TBL] [Abstract][Full Text] [Related]
13. Detection of pseudocapsule of renal cell carcinoma with MR imaging and CT.
Yamashita Y; Honda S; Nishiharu T; Urata J; Takahashi M
AJR Am J Roentgenol; 1996 May; 166(5):1151-5. PubMed ID: 8615260
[TBL] [Abstract][Full Text] [Related]
14. Gadolinium-enhanced MR imaging of thyroid and parathyroid masses.
Nakahara H; Noguchi S; Murakami N; Tamura S; Jinnouchi S; Kodama T; Adjei ON; Nagamachi S; Ohnishi T; Futami S; Flores LG; Watanabe K
Radiology; 1997 Mar; 202(3):765-72. PubMed ID: 9051032
[TBL] [Abstract][Full Text] [Related]
15. Detection of focal hepatic lesions with MR imaging: prospective comparison of T2-weighted fast spin-echo with and without fat suppression, T2-weighted breath-hold fast spin-echo, and gadolinium chelate-enhanced 3D gradient-recalled imaging.
Soyer P; de Givry SC; Gueye C; Lenormand S; Somveille E; Scherrer A
AJR Am J Roentgenol; 1996 May; 166(5):1115-21. PubMed ID: 8615254
[TBL] [Abstract][Full Text] [Related]
16. MR imaging of the myocardium using nonionic contrast medium: signal-intensity changes in patients with subacute myocardial infarction.
Dulce MC; Duerinckx AJ; Hartiala J; Caputo GR; O'Sullivan M; Cheitlin MD; Higgins CB
AJR Am J Roentgenol; 1993 May; 160(5):963-70. PubMed ID: 8470611
[TBL] [Abstract][Full Text] [Related]
17. MR imaging of peritoneal disease: comparison of contrast-enhanced fast multiplanar spoiled gradient-recalled and spin-echo imaging.
Low RN; Sigeti JS
AJR Am J Roentgenol; 1994 Nov; 163(5):1131-40. PubMed ID: 7976889
[TBL] [Abstract][Full Text] [Related]
18. Treatment of hepatocellular carcinoma with percutaneous ethanol injection: evaluation with contrast-enhanced MR imaging.
Bartolozzi C; Lencioni R; Caramella D; Mazzeo S; Ciancia EM
AJR Am J Roentgenol; 1994 Apr; 162(4):827-31. PubMed ID: 8141000
[TBL] [Abstract][Full Text] [Related]
19. Imaging of osteoid osteoma with dynamic gadolinium-enhanced MR imaging.
Liu PT; Chivers FS; Roberts CC; Schultz CJ; Beauchamp CP
Radiology; 2003 Jun; 227(3):691-700. PubMed ID: 12773675
[TBL] [Abstract][Full Text] [Related]
20. MR diagnosis of hepatic metastases from neuroendocrine tumors versus hemangiomas: relative merits of dynamic gadolinium chelate-enhanced gradient-recalled echo and unenhanced spin-echo images.
Soyer P; Gueye C; Somveille E; Laissy JP; Scherrer A
AJR Am J Roentgenol; 1995 Dec; 165(6):1407-13. PubMed ID: 7484575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]